Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022

BUY
$72.36 - $113.1 $35,962 - $56,210
497 Added 2.95%
17,317 $1.25 Million
Q2 2022

Aug 03, 2022

SELL
$87.2 - $114.05 $2,267 - $2,965
-26 Reduced 0.15%
16,820 $1.81 Million
Q1 2022

May 03, 2022

BUY
$94.19 - $124.49 $347,749 - $459,617
3,692 Added 28.07%
16,846 $1.87 Million
Q4 2021

Feb 04, 2022

SELL
$119.57 - $139.07 $593,665 - $690,482
-4,965 Reduced 27.4%
13,154 $1.68 Million
Q3 2021

Nov 02, 2021

SELL
$109.17 - $142.35 $173,471 - $226,194
-1,589 Reduced 8.06%
18,119 $2.41 Million
Q2 2021

Aug 03, 2021

SELL
$100.34 - $115.69 $163,453 - $188,459
-1,629 Reduced 7.63%
19,708 $2.13 Million
Q1 2021

May 03, 2021

SELL
$101.51 - $125.27 $61,921 - $76,414
-610 Reduced 2.78%
21,337 $2.25 Million
Q4 2020

Feb 03, 2021

SELL
$85.88 - $105.36 $115,938 - $142,236
-1,350 Reduced 5.79%
21,947 $2.28 Million
Q3 2020

Nov 02, 2020

SELL
$72.74 - $92.5 $10,911 - $13,875
-150 Reduced 0.64%
23,297 $2 Million
Q2 2020

Aug 03, 2020

SELL
$48.02 - $79.04 $492,733 - $811,029
-10,261 Reduced 30.44%
23,447 $1.72 Million
Q1 2020

Apr 28, 2020

BUY
$36.95 - $62.95 $354,165 - $603,375
9,585 Added 39.73%
33,708 $1.75 Million
Q4 2019

Feb 11, 2020

BUY
$47.06 - $56.64 $212,852 - $256,182
4,523 Added 23.08%
24,123 $1.36 Million
Q3 2019

Nov 06, 2019

SELL
$47.45 - $58.05 $86,928 - $106,347
-1,832 Reduced 8.55%
19,600 $934,000
Q2 2019

Aug 08, 2019

SELL
$39.26 - $54.21 $101,212 - $139,753
-2,578 Reduced 10.74%
21,432 $1.16 Million
Q1 2019

May 07, 2019

BUY
$29.84 - $43.92 $716,458 - $1.05 Million
24,010 New
24,010 $975,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Torray LLC Portfolio

Follow Torray LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Torray LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torray LLC with notifications on news.